Adrenocorticotropic hormone, also called corticotropin or ACTH, is a polypeptide hormone produced and secreted by the anterior pituitary gland. It is a core part of the hypothalamic-pituitary-adrenal axis, released during physical and psychological stress alongside corticotropin-releasing hormone from the hypothalamus. Its principal effect is to stimulate the adrenal cortex to increase production and release of cortisol and androgens. ACTH is a 39 amino acid peptide with a molecular weight of about 4540 daltons and a blood half-life of ten to thirty minutes, formed by cleavage of the larger precursor protein proopiomelanocortin. It acts by binding to ACTH receptors, seven-membrane-spanning G protein-coupled receptors found mainly on cells of the adrenal cortex. Beyond its role as a natural hormone, synthetic ACTH is used clinically both as a diagnostic agent to test adrenal gland function and as a treatment for certain conditions including infantile spasms. Low ACTH is associated with secondary and tertiary adrenal insufficiency, while persistently high ACTH marks primary adrenal insufficiency, and pituitary tumors that oversecrete ACTH cause Cushing's disease through the resulting excess cortisol.
Facts
Drug ClassNaturally sourced complex mixture of adrenocorticotropic hormone analogs and other pituitary peptides 1 Approved UseMonotherapy for the treatment of infantile spasms in infants and children under 2 years of age 1 First Approved / Isolated Year Significant RiskMay increase the risks related to infections with any pathogen, including viral, bacterial, fungal, protozoan or helminthic infections 1 Classification
Approval Status ATC ClassSourced to the subject's own accountH: Systemic Hormonal Preparations, Excluding Sex Hormones and Insulins 2 Route of Administration Partially Attested
Mechanism of ActionReported to bind to melanocortin receptors; the mechanism of action in infantile spasms is unknown 1 The label says the mechanism of action in infantile spasms is unknown and only reports binding to melanocortin receptors. Connections
Sources
1. National Library of Medicine DailyMed: ACTHAR (repository corticotropin) injection, DailyMed label
National Library of Medicine DailyMed1.1 Infantile Spasms
Acthar Gel is indicated as monotherapy for the treatment of infantile spasms in infants and children under 2 years of age.
11 Description, second sentence
The Acthar Gel manufacturing process converts the initial porcine pituitary extract with low ACTH content into a mixture having modified porcine ACTH and other related peptide analogs solubilized in gelatin.
11 Description, first sentence
Acthar Gel is a naturally sourced complex mixture of adrenocorticotropic hormone analogs and other pituitary peptides.
5.1 Infections, first sentence
Acthar Gel may increase the risks related to infections with any pathogen, including viral, bacterial, fungal, protozoan or helminthic infections.
12.1 Mechanism of Action, melanocortin sentence
Acthar Gel is also reported to bind to melanocortin receptors.
Highlights of prescribing information
Initial U.S. Approval: 1952
View the Source 2. Anatomical Therapeutic Chemical Classification System (Wikipedia)
WikipediaFirst-level anatomical group codes, Code HQuote, First-level anatomical group codes, Code H
Systemic hormonal preparations, excluding sex hormones and insulins
View the Source 3. Adrenocorticotropic hormone (Wikipedia)
4. Aetna Clinical Policy Bulletin: Repository Corticotropin Injection (Acthar Gel)
Approval historyQuote, Approval history
Repository corticotropin injection was originally approved by the U.S. Food and Drug Administration (FDA) in 1952 for a broad range of corticosteroid-responsive conditions including rheumatic, collagen, dermatologic, allergic states, ophthalmic, respiratory and edematous states.
View the Source Wikidata: ACTH
Wikidata Q185690, class allow-list match (w-wdresolver-0926)View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.